Previous 10 | Next 10 |
TORONTO, ON / ACCESSWIRE / February 21, 2020 / Eco (Atlantic) Oil & Gas Ltd. (AIM:ECO)(TSXV:EOG), the oil and gas exploration company with licences in highly prospective regions in South America and Africa, is delighted to announce it has been recognized as a 2020 TSX Venture 50™ ...
Falcon Oil & Gas Ltd. (“Falcon”) Successful Drilling of Kyalla 117 N2-1H ST2 Horizontal Well 20 February 2020 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that drilling operations, including casing and cementing, on the Kyalla 117...
TORONTO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (the “Company”), the AIM and TSXV quoted gold producer and explorer with a 100% interest in Northern Ireland’s Omagh gold mine, announces the results of the Special Meeting of the Shareholders (the ...
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTIO...
LONDON and REDWOOD CITY, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or the "Company," today announced that it has entered into a Securities Purchase Agreement (the “Agreement”) with a new U.S.-based institutional healt...
Bellerophon Therapeutics (NASDAQ: BLPH ) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis. More news on: Bellerophon Therape...
OCALA, FL / ACCESSWIRE / February 18, 2020 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today provided its stockholders with an update on its eff...
Calgary, Alberta and Houston, Texas--(Newsfile Corp. - February 18, 2020) - PetroTal Corp. (TSXV: TAL) (AIM: PTAL) (" PetroTal " or the " Company "), the Peruvian focused E&P company, is pleased to announce the results of its 2019 year-end reserve evaluation by Netherland, Sewell & Ass...
For immediate release 18 February 2020 Serabi Gold plc (“Serabi” or the “Company”) Corporate Presentation and update Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian focuse...
Hamburg-Eppendorf developed validated standardised Parsortix protocols for use in future clinical trials Parsortix harvested cells allow for "robust amplification of single cell DNA at excellent quality for subsequent molecular analysis" GUILDFORD, ENGLAND / ACCESSWIRE / Februa...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...